A164T (p.Ala164Thr) variant of ACE2 (Angiotensin-converting enzyme 2)
A164T (p.Ala164Thr) in ACE2 (Angiotensin-converting enzyme 2) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The record also includes structural context.
A164T (p.Ala164Thr) variant details
- p.Ala164Thr
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available